Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 3, 2003 - Issue 2
Submit an article Journal homepage
24
Views
2
CrossRef citations to date
0
Altmetric
Review

Measuring quality of life and utilities in esophageal cancer

Paul McNamee Health Economics Research Unit, Institute of Applied Health Sciences, University Medical Buildings, Foresterhill, Aberdeen, AB25 2ZD, UK. [email protected]
,
Jon Shenfine Health Economics Research Unit, Institute of Applied Health Sciences, University Medical Buildings, Foresterhill, Aberdeen, AB25 2ZD, UK. [email protected]
&
John Bond Health Economics Research Unit, Institute of Applied Health Sciences, University Medical Buildings, Foresterhill, Aberdeen, AB25 2ZD, UK. [email protected]
Pages 179-188 | Published online: 09 Jan 2014

References

  • Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int.j Cancer 55(6), 891–903 (1993).
  • Dolan K, Sutton R, Walker SJ, Morris Al, Campbell F, Williams EM. New classification of esophageal and gastric carcinomas derived from changing patterns in epidemiology. BE j Cancer 80 (5-6), 834–842 (1999).
  • Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83(10), 2049–2053 (1998).
  • McKinney A, Sharp L, Macfarlane GJ, Muir CS. Esophageal and gastric cancer in Scotland 1960–1990. Br. Cancer 71(2), 411–415 (1995).
  • Office for National Statistics. Mortality Statistics. Review of the Registrar General on Deaths by Cause, Sex and Age, in England and Wales 1997 Series DH2 No.24 (Table 3), 96–97 (1997).
  • Earlam R, Cunha-Melo JR. Esophageal squamous cell carcinoma: I. A critical review of surgery. Br Sing 67(6), 381–390 (1980).
  • Tekkis PP, Kocher HM, Bentley AJ et al Operative mortality rates among surgeons: comparison of POSSUM and p-POSSUM scoring systems in gastrointestinal surgery. Dis. Colon Rectum 43(11), 1528–1532 (2000).
  • Dresner SM, Lamb PJ, Shenfine J, Hayes N, Griffin SM. Prognostic significance of peri-operative blood transfusion following radical resection for esophageal carcinoma. Eur. Surg. Oncol 26(5), 492–497 (2000).
  • Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of esophageal carcinoma. BE j Surg. 77(8), 845–857 (1990).
  • Barr H, Krasner N. Prospective quality-of-life analysis after palliative photoablation for the treatment of malignant dysphagia. Cancer 68 (7), 1660–1664 (1991).
  • Loizou LA, Grigg D, Atkinson M, Robertson C, Bown SG. A prospective comparison of laser therapy and intubation in endoscopic palliation for malignant dysphagia. Castroentemlogy100(5), 1303–1310 (1991).
  • Blazeby JM, Alderson D, Famdon JR. Quality of life in patients with esophageal cancer. Recent Results Cancer Res. 155,193–204 (2000).
  • •Recent review of quality of life measures in esophageal cancer.
  • Blazeby JM, Williams MET, Alderson D, Farndon JR. Observer variation in assessment of quality of life in patients with esophageal cancer. Br. Sing 82(9), 1200–1203 (1995).
  • Blazeby JM, Williams MET, Brookes ST, Alderson D, Famdon JR. Quality of life measurement in patients with esophageal cancer. Gut 37(4), 505–508 (1995).
  • Watson A. A study of the quality and duration of survival following resection, endoscopic intubation and surgical intubation in esophageal carcinoma. BE j Surg. 69(10), 585–588 (1982).
  • Diamantes T, Mannell A. Esophageal intubation for advanced esophageal cancer: the Baragwanath experience 1977–1981. Br. Surg. 70(9), 555–557 (1983).
  • Brunelli C, Mosconi P, Boeri P, et al Evaluation of quality of life in patients with malignant dysphagia. Tumor86(2), 134–138 (2000).
  • Loizou LA, Rampton D, Atkinson M, Robertson C, Bown SG. A prospective assessment of quality of life after endoscopic intubation and laser therapy for malignant dysphagia. Cancer 70 (2), 386–391 (1992) .
  • Blazeby JM, Alderson D, Winstone K etal Development of an EORTC questionnaire module to be used in quality of life assessment for patients with esophageal cancer. The EORTC Quality of Life Study Group. Eui:j Cancer32A(11), 1912–1917, (1996).
  • van Knippenberg FC, Out JJ, Tilanus HW, Mud HJ, Hop WC, Verhage F. Quality of Life in patients with resected esophageal cancer. Soc. Sci. Med 35(2), 139–145 (1992).
  • McLarty AJ, Deschamps C, Trastek VF, Allen MS, Pairolero PC, Harmsen WS. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann. Thor Surg. 63(6), 1568–1572 (1997).
  • Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Healthcare Programmes. Oxford University Press, Oxford, UK (1997).
  • Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus (Cochrane Review). In: The Cochrane Library Issue 1, (2003).
  • Blazeby JM, Famdon JR, Donovan J, Alderson D. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 88(8), 1781–1787 (2000).
  • •One of the first studies testing EORTC QLQ-C30 with longitudinal data.
  • Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens Pet al Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl. J. Med. 347(21), 1662–1669 (2002).
  • Nicholson D A, Haycox A, Kay C L, Rate A, Attwood S, Bancewicz J. The cost effectiveness of metal esophageal stenting in malignant disease compared with conventional therapy. Clin. Radiol. 54(4), 212–215 (1999).
  • O'Donnell CA, Fullarton GM, Watt E, Lennon K, Murray GD, Moss JG. Randomized clinical trial comparing self-expanding metallic stents with plastic endoprostheses in the palliation of esophageal cancer. BE J. Surg. 89(8), 985–992 (2002).
  • Stoller JL, Samer KJ, Toppin DI, Flores AD. Carcinoma of the esophagus: a new proposal for the evaluation of treatment. Can. Surg. 20(5), 454–459 (1977).
  • Gelfand GA, Finley RJ. Quality of life with carcinoma of the esophagus. Worldj Surg: 18(3), 399–405 (1994).
  • •First review paper assessing QOL in esophageal cancer.
  • Schipper H, Clinch J, Powell V Definitions and conceptual issues. In: Quality of life assessments in clinical trials. B. Spilker (Ed). New York, USA, Raven Press, 11–24 (1990).
  • Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health 7echnol Assess. 2(14), 1–74 (1998).
  • •Informative review of outcome measures for use in clinical trials.
  • McDowell I, Newell C. Measuring- Health: A Guide to Rating Scales and Questionnaires. Oxford University Press, Oxford, UK (1996).
  • Karnofsky DA, Abalmann WH, Craver LF, Burchenal JH. The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1,634–656 (1948).
  • Schag CC, Heinrich RL, Ganz PA. Kamofsky performance status revisited: Reliability, validity and guidelines. j Clin. Oncology2, 187–193 (1984).
  • Spitzer WO, Dobson AJ, Chesterman E, Levi J, Shepherd R, Battista RE eta]. Measuring the quality of life of cancer patients. J. Chron. Dis. 34,585–597 (1981).
  • Ware JE, Kosinski M. SF-368 Physical and mental health summary scales: a manual for users of version 1, (2nd Edition). QualityMetric, Inc., Lincoln, RI, USA (2001).
  • Gandek B,Ware Jr J E,Aaronson NK eta]. Tests of data quality, scaling assumptions and reliability of the SF- 36 in eleven countries: results from the IQOLA Project.j Clin. Epidemiol 51 (11), 1149–1158, (1998).
  • Ware Jr J, Kosinski M, Keller SD. A 12- Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med. Cam 34(3), 220–233 (1996).
  • Brooks R. EuroQ0L: the current state of play. Health Poi 37(1), 53–72 (1996).
  • Wu AW, Jacobson DL, Frick KD, Clark R, Revicki DA, Freedberg IKA etal Validity and responsiveness of the EuroQol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res. 11(3), 272–283 (2002).
  • Luo N, Chew LH, Fong KY, Koh DR eta]. Validity and reliability of the EQ-5D self-report questionnaire in English speaking Asian patients with rheumatic diseases in Singapore. Qual Life Res. 12(1), 87–92 (2003).
  • Conner-Spady B, Cumming C, Nabholtz J-M, Jacobs P, Stewart D. Responsiveness of the EuroQol in breast cancer patients undergoing high dose chemotherapy. Qua'. Life Res. 10(6), 479–486 (2001).
  • Aaronson NK, Ahmedzai S, Bergman B etal The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Nat. Cancer Inst. 85(5), 365–376 (1993).
  • •Main EORTCQLQ-C30 paper describing development of the measure.
  • Famdon MA, Wayman J, Clague MB, Griffin SM. Cost-effectiveness in the management of patients with esophageal cancer. Br. Surg. 85(10), 1394–1398 (1998).
  • Sneeuw KC, Aaronson NK, Sprangers MA, Detmar SB, Weyer LD, Schomagel JH. Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. j Clin. Epidemiol 51(7), 617–631 (1998).
  • Cella DF, Tulsky DS, Gray G etal The Functional Assessment of Cancer Therapy (FACT) scale: Development and validation of the general measure. J. Clin. arca 11(3), 570–579 (1993).
  • Brooks JA, Kesler KA, Johnson CS, Ciaccia D, Brown JW. FACT- G: Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results. Surg. Oncol 81(4), 185–194 (2002).
  • Kemmler G, Holzner B, Kopp MR et al Comparison of two quality of life instruments for cancer patients: the Functional Assessment of Cancer Therapy-General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. j Clin. Oncol 17,2932–2940 (1999).
  • Clark A, Fallowfield U. Quality of life measurements in patients with malignant disease: a review. I Royal Soc. Med. 79(3), 165–169 (1986).
  • McNeil BJ, Weichselbaum R, Pauker SG. Fallacy of the five-year survival in lung cancer. N. Engl. Med 299(25), 1397–1401 (1978).
  • Goligher JC. Judging the quality of life after surgical operations. I Chronic Dis. 40, 631–633 (1987).
  • Torrance GW. Measurement of health state utilities for economic appraisal. j Health Econ. 5(1), 1–30 (1986).
  • ••Landmark paper describing health statevaluation techniques.
  • de Haes JCJM, Stiggelbout AM. Assessment of values, utilities and preferences in cancer patients. Cancer Tmat.Rev. 22,13–26 (1996).
  • Stiggelbout AM, Kiebert GM, Kievit J, Leer JWH, Habbema JDF, de Haes JCJM. The 'utility' of the time trade-off method in cancer patients: Feasibility and proportional trade-off. J. Clin. Epidemiol 48,1207–1214 (1995).
  • Van der Donk J, Levendag PC, Kuijpers AJ et al Patient participation in clinical decision-making for treatment of T3 laryngeal cancer: A comparison of state and process utilities. j Gun. Onto" 13,2369–2378 (1995).
  • Llewellyn-Thomas H, Sutherland HJ, Tibshirani R, Ciampi A, Till JE, Boyd NE The measurement of patients' values. Med Decis. Making2, 449–462 (1982).
  • Rutten-van Milken MP, Bakker CH, van Doorslaer EK, van der Linden S. Methodological issues of patient utility measurement: Experience from two clinical trials. Med Cam 33,922–937 (1995).
  • Morrison GC, Neilson A, Malek M. Improving the sensitivity of the time trade off method: Results of an experiment using chained Tilt) questions. Department of Economics Discussion Paper No.98/22, University of Nottingham: Nottingham, UK, (1998).
  • Stalmeier PPM. Discrepancies between chained and classic utilities induced by anchoring with occasional adjustments. Med Decis. Making 22,53–64 (2002).
  • Jansen SJ, Stiggelbout AM, Wakker PP et al. Patients' utilities for cancer treatments: a study of the chained procedure for the standard gamble and time tradeoff. Med Decis. Making 18, 391–399 (1998).
  • Froberg DG, Kane RL. Methodology for measuring health state preferences-III: Population and context effects. J Clin. Epidemiol 42(6), 585–592 (1989).
  • ••Key methodology paper in health statevaluation.
  • Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science 211,453–458 (1981).
  • Kahneman, Tversky A. The psychology of preference. Sci. Am. 246,160–173 (1982).
  • Dolan P. Modelling valuations for health states: the effect of duration. Health Pol. 38, 189–203 (1996).
  • Cook J, Richardson J, Street A. Cost utility analysis of treatment options for gallstone disease: Methodological issues and results. Health Econ. 3,157–168 (1994).
  • Bleichrodt H, Johannesson M. An experimental test of constant proportional tradeoff and utility independence. Med Decis. Making17,21–32 (1996).
  • Llewellyn-Thomas HA, Thiel EC, McGreal MJ. Cancer patients' evaluations of their current health states: the influence of expectations, comparisons, actual health status and mood. Med Decis. Making12, 115–122 (1992).
  • Llewellyn-Thomas HA, Sutherland HJ, Thiel EC. Do patients evaluations of a future health state change when they actually enter that state? Med Cate 31,1002–1012 (1993).
  • de Boer AG, Stalmeier PF, Sprangers MA et al Transhiatal versus extended transthoracic resection in esophageal carcinoma: patients' utilities and treatment preferences. BE j Cancer 86(6), 851–857 (2002).
  • •One of the first published studies describing application of health state valuation techniques in esophageal cancer.
  • Brazier J. Roberts J. Deverill M. The estimation of a preference-based measure of health from the SF-36. 'Health Econ. 21(2), 271–292 (2002).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.